New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths
Go back to New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 108.40 +0.80 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.60 | 52 Week High | $39.41 | |||
| Open | $108.95 | 52 Week Low | $25.98 | |||
| Day High | $110.45 | P/E | 152.68 | |||
| Day Low | $107.60 | EPS | $0.71 | |||
| Volume | 1,300,442 | |||||
